Compare J.B.Chemicals with Aventis Pharma - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

J.B.CHEMICALS vs SANOFI INDIA - Comparison Results

J.B.CHEMICALS     Change

JB Chemicals and Pharmaceuticals Limited (JBCPL), the flagship of the Unique Group, is one of the India's leading transnational pharmaceutical company. The company has 11 manufacturing facilities at four locations in India (Belapur, Ankleshwar, Panol... More

SANOFI INDIA 
   Change

Sanofi India (the erstwhile Aventis Pharma), the 60% subsidiary of Sanofi-Aventis SA, France, is one of the largest pharma MNCs in India with a turnover of over Rs 13.2 bn in CY11. Domestic sales constituted 81% of total sales in CY11 and exports con... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    J.B.CHEMICALS SANOFI INDIA J.B.CHEMICALS/
SANOFI INDIA
 
P/E (TTM) x 22.8 43.2 52.7% View Chart
P/BV x 4.2 7.9 53.5% View Chart
Dividend Yield % 0.3 1.1 25.2%  

Financials

 J.B.CHEMICALS   SANOFI INDIA
EQUITY SHARE DATA
    J.B.CHEMICALS
Mar-18
SANOFI INDIA
Dec-18
J.B.CHEMICALS/
SANOFI INDIA
5-Yr Chart
Click to enlarge
High Rs3636,840 5.3%   
Low Rs2554,630 5.5%   
Sales per share (Unadj.) Rs169.11,203.1 14.1%  
Earnings per share (Unadj.) Rs16.6165.3 10.0%  
Cash flow per share (Unadj.) Rs23.4209.9 11.2%  
Dividends per share (Unadj.) Rs2.0084.00 2.4%  
Dividend yield (eoy) %0.61.5 44.2%  
Book value per share (Unadj.) Rs172.5963.6 17.9%  
Shares outstanding (eoy) m83.5723.03 362.9%   
Bonus/Rights/Conversions BB--  
Price / Sales ratio x1.84.8 38.3%   
Avg P/E ratio x18.634.7 53.7%  
P/CF ratio (eoy) x13.227.3 48.3%  
Price / Book Value ratio x1.86.0 30.1%  
Dividend payout %12.050.8 23.7%   
Avg Mkt Cap Rs m25,827132,078 19.6%   
No. of employees `0003.83.3 114.3%   
Total wages/salary Rs m2,5114,068 61.7%   
Avg. sales/employee Rs Th3,747.48,393.8 44.6%   
Avg. wages/employee Rs Th665.71,232.4 54.0%   
Avg. net profit/employee Rs Th367.81,153.0 31.9%   
INCOME DATA
Net Sales Rs m14,13527,708 51.0%  
Other income Rs m366897 40.8%   
Total revenues Rs m14,50128,605 50.7%   
Gross profit Rs m2,1786,235 34.9%  
Depreciation Rs m5701,027 55.5%   
Interest Rs m357 498.6%   
Profit before tax Rs m1,9406,098 31.8%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m5522,292 24.1%   
Profit after tax Rs m1,3873,806 36.4%  
Gross profit margin %15.422.5 68.5%  
Effective tax rate %28.537.6 75.8%   
Net profit margin %9.813.7 71.4%  
BALANCE SHEET DATA
Current assets Rs m10,47015,922 65.8%   
Current liabilities Rs m2,7496,235 44.1%   
Net working cap to sales %54.635.0 156.2%  
Current ratio x3.82.6 149.1%  
Inventory Days Days5564 86.7%  
Debtors Days Days7821 372.2%  
Net fixed assets Rs m5,8117,539 77.1%   
Share capital Rs m167230 72.7%   
"Free" reserves Rs m14,24821,962 64.9%   
Net worth Rs m14,41622,192 65.0%   
Long term debt Rs m00-   
Total assets Rs m17,64929,839 59.1%  
Interest coverage x56.6872.1 6.5%   
Debt to equity ratio x00-  
Sales to assets ratio x0.80.9 86.3%   
Return on assets %8.112.8 63.1%  
Return on equity %9.617.2 56.1%  
Return on capital %13.727.5 49.8%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m6,1647,587 81.2%   
Fx outflow Rs m1,3347,145 18.7%   
Net fx Rs m4,829442 1,092.6%   
CASH FLOW
From Operations Rs m1,2313,739 32.9%  
From Investments Rs m-208-731 28.5%  
From Financial Activity Rs m-595-1,972 30.2%  
Net Cashflow Rs m4271,036 41.2%  

Share Holding

Indian Promoters % 55.4 0.0 -  
Foreign collaborators % 0.3 60.4 0.5%  
Indian inst/Mut Fund % 3.4 14.4 23.5%  
FIIs % 3.9 14.6 26.7%  
ADR/GDR % 0.0 0.0 -  
Free float % 37.0 10.5 352.4%  
Shareholders   30,437 15,184 200.5%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare J.B.CHEMICALS With:   PANACEA BIOTECH  BIOCON   FULFORD INDIA  NATCO PHARMA  AJANTA PHARMA  

Compare J.B.CHEMICALS With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

PNB Reports DHFL Fraud, TCS June Quarter Numbers, and Top Buzzing Stocks Today(Pre-Open)

Indian share markets witnessed selling pressure on Friday, tracking weak global cues as coronavirus cases continue to surge across the world.

Related Views on News

SANOFI INDIA Announces Quarterly Results (4QFY20); Net Profit Down 8.1% (Quarterly Result Update)

May 21, 2020 | Updated on May 21, 2020

For the quarter ended March 2020, SANOFI INDIA has posted a net profit of Rs 854 m (down 8.1% YoY). Sales on the other hand came in at Rs 8 bn (up 9.4% YoY). Read on for a complete analysis of SANOFI INDIA's quarterly results.

J.B.CHEMICALS Announces Quarterly Results (3QFY20); Net Profit Up 34.1% (Quarterly Result Update)

Feb 6, 2020 | Updated on Feb 6, 2020

For the quarter ended December 2019, J.B.CHEMICALS has posted a net profit of Rs 622 m (up 34.1% YoY). Sales on the other hand came in at Rs 4 bn (up 9.3% YoY). Read on for a complete analysis of J.B.CHEMICALS's quarterly results.

SANOFI INDIA Announces Quarterly Results (1QFY20); Net Profit Down 2.2% (Quarterly Result Update)

Jul 31, 2019 | Updated on Jul 31, 2019

For the quarter ended June 2019, SANOFI INDIA has posted a net profit of Rs 974 m (down 2.2% YoY). Sales on the other hand came in at Rs 7 bn (up 9.4% YoY). Read on for a complete analysis of SANOFI INDIA's quarterly results.

J.B.CHEMICALS Announces Quarterly Results (4QFY19); Net Profit Up 91.2% (Quarterly Result Update)

May 24, 2019 | Updated on May 24, 2019

For the quarter ended March 2019, J.B.CHEMICALS has posted a net profit of Rs 422 m (up 91.2% YoY). Sales on the other hand came in at Rs 4 bn (up 18.9% YoY). Read on for a complete analysis of J.B.CHEMICALS's quarterly results.

SANOFI INDIA Announces Quarterly Results (4QFY19); Net Profit Up 12.6% (Quarterly Result Update)

May 8, 2019 | Updated on May 8, 2019

For the quarter ended March 2019, SANOFI INDIA has posted a net profit of Rs 929 m (up 12.6% YoY). Sales on the other hand came in at Rs 7 bn (up 16.1% YoY). Read on for a complete analysis of SANOFI INDIA's quarterly results.

More Views on News

Most Popular

How to Find the Best Stocks for Day Trading - 1(Fast Profits Daily)

Jul 2, 2020

In the first of two videos, I'll show you how to identify the best stocks for intraday trading.

Two Agri Stocks Are Likely to Outperform Even in this Market(Profit Hunter)

Jul 2, 2020

Why we have recommended two agriculture stocks for our Hidden Treasure subscribers. Read on...

A Warning for Traders: Don't Get Addicted to Hopium(Fast Profits Daily)

Jun 30, 2020

If you are a trader, you must watch out for this dangerous addiction.

Smallcaps Are in a Sweet Spot Again: Are You Buying?(Profit Hunter)

Jul 3, 2020

This is why I believe smallcaps are the place to be in the near future.

More

India's #1 Trader
Reveals His Secrets

The Secret to Increasing Your Trading Profits Today
Get this Special Report, The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

J.B.CHEMICALS SHARE PRICE


Jul 10, 2020 (Close)

TRACK J.B.CHEMICALS

  • Track your investment in J.B.CHEMICALS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

J.B.CHEMICALS 8-QTR ANALYSIS

COMPARE J.B.CHEMICALS WITH

MARKET STATS